These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 15270596

  • 1. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
    Yang X, Wasserman PG, Bhargava A, Iqbal U, Ragnauth S, Fuchs A.
    Arch Pathol Lab Med; 2004 Aug; 128(8):e100-3. PubMed ID: 15270596
    [Abstract] [Full Text] [Related]

  • 2. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement.
    Nagata T, Higashigawa M, Nagai M, Zhang XL, Azuma E, Komada Y, Sakurai M.
    Leuk Res; 1996 Aug; 20(11-12):983-5. PubMed ID: 9009257
    [Abstract] [Full Text] [Related]

  • 3. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
    Scott AA, Head DR, Kopecky KJ, Appelbaum FR, Theil KS, Grever MR, Chen IM, Whittaker MH, Griffith BB, Licht JD.
    Blood; 1994 Jul 01; 84(1):244-55. PubMed ID: 7517211
    [Abstract] [Full Text] [Related]

  • 4. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
    Handa H, Motohashi S, Isozumi K, Komatsumoto S, Nara M.
    Acta Haematol; 2002 Jul 01; 108(1):47-52. PubMed ID: 12145468
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
    Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH, Cheung MM, Lau WH.
    Blood; 1997 Jun 15; 89(12):4501-13. PubMed ID: 9192774
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.
    DiGiuseppe JA, Louie DC, Williams JE, Miller DT, Griffin CA, Mann RB, Borowitz MJ.
    Am J Surg Pathol; 1997 Oct 15; 21(10):1223-30. PubMed ID: 9331296
    [Abstract] [Full Text] [Related]

  • 9. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T, Kimura N, Sawada H, Suematsu E, Nagano M, Akiyoshi T, Motomura S, Kikuchi M, Nishimura J, Tamura K.
    Intern Med; 1999 Jul 15; 38(7):547-55. PubMed ID: 10435360
    [Abstract] [Full Text] [Related]

  • 10. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.
    Ai Zheng; 2007 Apr 15; 26(4):418-22. PubMed ID: 17430665
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hematodermic CD4/CD56 neoplasm].
    Petrella T, Wechsler J, Courville P, de Muret A, Bosq J, Déchelotte P, Feuillard J, Durlach A, Vergier B.
    Ann Pathol; 2004 Jun 15; 24(3):241-55; quiz 227. PubMed ID: 15480259
    [Abstract] [Full Text] [Related]

  • 13. Uncommon cases of immature-type CD56+ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphoma.
    Owatari S, Otsuka M, Takeshita T, Mizukami K, Suzuki S, Uozumi K, Tashiro Y, Arima N, Hanada S.
    Int J Hematol; 2009 Mar 15; 89(2):188-194. PubMed ID: 19109730
    [Abstract] [Full Text] [Related]

  • 14. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG, Jin YM, Niu Q, Zeng TT, Su J, Zhu HL.
    Ann Hematol; 2013 Jan 15; 92(1):89-96. PubMed ID: 22992980
    [Abstract] [Full Text] [Related]

  • 15. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG, Chen XM, Zhu HL, Zhong L, Zeng TT, Jia YQ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec 15; 18(6):1405-9. PubMed ID: 21176339
    [Abstract] [Full Text] [Related]

  • 16. Natural killer cell precursor acute lymphoma/leukemia presenting in an infant.
    Natkunam Y, Cherry AM, Cornbleet PJ.
    Arch Pathol Lab Med; 2001 Mar 15; 125(3):413-8. PubMed ID: 11231495
    [Abstract] [Full Text] [Related]

  • 17. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
    Yamada O, Ichikawa M, Okamoto T, Park C, Motoji T, Mizoguchi H, Shibuya A.
    Br J Haematol; 2001 Apr 15; 113(1):153-60. PubMed ID: 11328295
    [Abstract] [Full Text] [Related]

  • 18. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
    Suzuki R, Nakamura S.
    Leuk Res; 1999 Jul 15; 23(7):615-24. PubMed ID: 10400182
    [Abstract] [Full Text] [Related]

  • 19. CD56 (NCAM)-positive malignant lymphoma.
    Wong KF, Chan JK, Ng CS.
    Leuk Lymphoma; 1994 Jun 15; 14(1-2):29-36. PubMed ID: 7522719
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.